# Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

> **NCT06382389** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 96 (estimated)

## Conditions studied

- Depression
- Neurocognitive Disorders

## Interventions

- **DRUG:** EMONO
- **DRUG:** Medical air

## Key facts

- **NCT ID:** NCT06382389
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06382389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06382389, "Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06382389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*